Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-01-30FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
FDA approved a supplemental application for Zoloft (sertraline hydrochloride) submitted by ROERIG.
-
FDA approval · 2009-01-30FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for PAROXETINE HYDROCHLORIDE from Apotex Corp.
-
FDA approval · 2009-01-30FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
FDA approved a supplemental application from Apotex Corp for Paxil (paroxetine hydrochloride), authorizing a generic version under the exist…
-
FDA approval · 2009-01-30FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approves a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2009-01-30FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for an extended-release formulation of Pristiq (desvenlafaxine succinate) by Wyeth Pharmaceutica…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-01-30FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)
FDA approves a supplemental application for Celexa (citalopram) from Allergan, Inc.
-
FDA approval · 2009-01-27FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for venlafaxine hydrochloride, enabling marketing of a generic venlafaxine hydrochloride produc…
-
FDA approval · 2009-01-23FDA Approved: CITALOPRAM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Citalopram from Torrent Pharmaceuticals Limited, confirming approval of a supplemental change to…
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: VISN 20: Prophylactic Treatment of Interferon-Induced Depression in Hepatitis C Patients [Phase 4]
This Phase 4 clinical trial update reports the completion of a study evaluating prophylactic treatment to prevent interferon-induced depress…
-
CLINICAL_TRIALS research · 2009-01-21Clinical Trial Update: Biological Aspects of Depression and Antidepressant Drugs [NA]
This entry reports a completed clinical trial exploring the biological aspects of depression and antidepressant drugs.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients [Phase 4]
Phase 4 trial evaluating treatment effects on platelet calcium in adults with depression and hypertension; study completed.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Transcranial Magnetic Stimulation in Depression [Phase 1]
This update notes the completion of a Phase 1 trial evaluating transcranial magnetic stimulation for depression conducted by the US Departme…
-
CLINICAL_TRIALS trial_result · 2009-01-16Clinical Trial Update: An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder [Phase 2]
Phase 2 trial evaluating two fixed doses of SSR149415 (250 mg twice daily and 100 mg twice daily) in patients with major depressive disorder…
-
FDA approval · 2009-01-14FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Citalopram hydrobromide manufactured by Aurobindo Pharma Limited.
-
FDA approval · 2009-01-13FDA Approved: CITALOPRAM HYDROBROMIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Citalopram hydrobromide from Aurobindo Pharma Limited, authorizing its approval as a generic ant…
-
FDA approval · 2009-01-09FDA Approved: VENLAFAXINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a generic venlafaxine product under Heritage Pharmaceuticals’ original ANDA, for the treatment of major depressive disorder and…
-
CLINICAL_TRIALS trial_result · 2009-01-07Clinical Trial Update: Transforming Psychotherapy for Chronically Ill Patients [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial evaluating psychotherapy for chronically ill patients, including those with heart failure, COPD, …
-
CLINICAL_TRIALS research · 2008-12-31Clinical Trial Update: DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome [Phase 4]
Phase 4 trial evaluating escitalopram to prevent depression in patients with acute coronary syndrome; the current status of the study is unk…
-
CLINICAL_TRIALS research · 2008-12-25Clinical Trial Update: Detection and Treatment of Depression in Patients Admitted to the General Hospital [Phase 2]
Phase 2 clinical trial led by Radboud University Medical Center evaluating detection and treatment of depression in patients admitted to a g…
-
CLINICAL_TRIALS trial_result · 2008-12-23Clinical Trial Update: An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of Saredutant in patients with depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2008-12-22Clinical Trial Update: Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder [Phase 3]
A Phase 3 trial assessing the efficacy of Seroquel SR in combination with an antidepressant for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2008-12-22Clinical Trial Update: Neurotrophic Factors and Depression [Phase 4]
Phase 4 clinical trial evaluating neurotrophic factors for depression has been completed.
-
FDA approval · 2008-12-19FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
The FDA approved a supplemental application for bupropion hydrochloride submitted by Apnar Pharma LP.
-
CLINICAL_TRIALS trial_result · 2008-12-18Clinical Trial Update: SA4503 8-Week Study in Major Depressive Disorder (MDD) [Phase 2]
A Phase 2 trial of SA4503 for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2008-12-05Clinical Trial Update: Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder [Phase 2]
Phase 2 trial evaluating DOV-21,947 for major depressive disorder reported efficacy and safety data, with the study status listed as termina…